Bone-Targeting Radionuclides in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review on Radium-223 Chloride (Alpharadin) in Combination with Other Therapies

Bone-Targeting Radionuclides in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review on Radium-223 Chloride (Alpharadin) in Combination with Other Therapies

Recent advances have broadened the range of therapeutic options for mCRPC, with several new treatments, including novel hormonal therapies (enzalutamide, abiraterone), chemotherapeutic agents (docetaxel, cabazitaxel), immunotherapies (sipuleucel-T), and bone targeting radiopharmaceuticals (radium-22...

Full description

Saved in:
Bibliographic Details
Main Author: Ali H. D. Alshehri
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Diagnostics
Subjects:
prostate cancer
bone metastasis
radium-223 therapy
Online Access:https://www.mdpi.com/2075-4418/14/21/2407
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items